1. Home
  2. ANDE vs IOVA Comparison

ANDE vs IOVA Comparison

Compare ANDE & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANDE
  • IOVA
  • Stock Information
  • Founded
  • ANDE 1947
  • IOVA 2007
  • Country
  • ANDE United States
  • IOVA United States
  • Employees
  • ANDE N/A
  • IOVA N/A
  • Industry
  • ANDE Farming/Seeds/Milling
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ANDE Industrials
  • IOVA Health Care
  • Exchange
  • ANDE Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • ANDE 1.4B
  • IOVA 1.2B
  • IPO Year
  • ANDE N/A
  • IOVA N/A
  • Fundamental
  • Price
  • ANDE $43.26
  • IOVA $3.56
  • Analyst Decision
  • ANDE Buy
  • IOVA Strong Buy
  • Analyst Count
  • ANDE 1
  • IOVA 8
  • Target Price
  • ANDE $55.00
  • IOVA $20.25
  • AVG Volume (30 Days)
  • ANDE 446.7K
  • IOVA 9.4M
  • Earning Date
  • ANDE 05-06-2025
  • IOVA 05-08-2025
  • Dividend Yield
  • ANDE 1.81%
  • IOVA N/A
  • EPS Growth
  • ANDE 12.93
  • IOVA N/A
  • EPS
  • ANDE 3.32
  • IOVA N/A
  • Revenue
  • ANDE $11,257,548,000.00
  • IOVA $164,070,000.00
  • Revenue This Year
  • ANDE $5.97
  • IOVA $180.51
  • Revenue Next Year
  • ANDE $4.31
  • IOVA $59.81
  • P/E Ratio
  • ANDE $12.96
  • IOVA N/A
  • Revenue Growth
  • ANDE N/A
  • IOVA 13698.99
  • 52 Week Low
  • ANDE $39.25
  • IOVA $3.33
  • 52 Week High
  • ANDE $61.46
  • IOVA $14.77
  • Technical
  • Relative Strength Index (RSI)
  • ANDE 52.22
  • IOVA 33.72
  • Support Level
  • ANDE $41.63
  • IOVA $3.33
  • Resistance Level
  • ANDE $44.02
  • IOVA $3.66
  • Average True Range (ATR)
  • ANDE 1.22
  • IOVA 0.21
  • MACD
  • ANDE 0.07
  • IOVA 0.07
  • Stochastic Oscillator
  • ANDE 64.83
  • IOVA 33.82

About ANDE Andersons Inc. (The)

Andersons Inc is a diversified company with its main focus in the agriculture sector. Its operations are segmented into Trade, Renewables, and Nutrient & Industrial. The Trade segment, which generates the majority of the revenue, is engaged in the movement of physical commodities such as whole grains, grain products, feed ingredients, and domestic fuel products, among other agricultural commodities. Geographically, the company generates the majority of its revenue from the United States and the rest from Canada, Mexico, Egypt, Switzerland, and other markets.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: